The Benchmark Company Announces Closing of Public Offering of $4.5m for Seelos Therapeutics, Inc. NEW YORK, March 17, 2020 (GLOBE NEWSWIRE) -- The Benchmark Company today announced the closing on March 16th of an Underwritten Public Offering for Seelos Therapeutics, Inc. of 7,500,000 shares of...

The Benchmark Company Expands Its Biotechnology Focus With The Addition Of Dr. Aydin Huseynov And Dr. Okechukwu Linton NEW YORK, Feb. 26, 2020 (GLOBE NEWSWIRE) -- The Benchmark Company, LLC, an institutionally focused research, sales & trading, and investment banking firm covering multiple sectors, including...